Dual Biologic therapy- is it safe in patients with concomitant severe asthma and other immune-mediated diseases?
M. Navarrete Rouco (Barcelona (Barcelona), Spain), N. Carballo (Barcelona (Barcelona), Spain), I. Bobolea (Barcelona (Barcelona), Spain), E. Martínez-Moragón (Barcelona (Barcelona), Spain), S. Pascual.Erquicia (Barcelona (Barcelona), Spain), M. Labrador (Barcelona (Barcelona), Spain), M. Rancionero (Barcelona (Barcelona), Spain), P. Ausin (Barcelona (Barcelona), Spain)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2133
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Navarrete Rouco (Barcelona (Barcelona), Spain), N. Carballo (Barcelona (Barcelona), Spain), I. Bobolea (Barcelona (Barcelona), Spain), E. Martínez-Moragón (Barcelona (Barcelona), Spain), S. Pascual.Erquicia (Barcelona (Barcelona), Spain), M. Labrador (Barcelona (Barcelona), Spain), M. Rancionero (Barcelona (Barcelona), Spain), P. Ausin (Barcelona (Barcelona), Spain). Dual Biologic therapy- is it safe in patients with concomitant severe asthma and other immune-mediated diseases?. 2133
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|